237 related articles for article (PubMed ID: 23195331)
1. αC helix displacement as a general approach for allosteric modulation of protein kinases.
Palmieri L; Rastelli G
Drug Discov Today; 2013 Apr; 18(7-8):407-14. PubMed ID: 23195331
[TBL] [Abstract][Full Text] [Related]
2. Strategies for the selective regulation of kinases with allosteric modulators: exploiting exclusive structural features.
Fang Z; Grütter C; Rauh D
ACS Chem Biol; 2013 Jan; 8(1):58-70. PubMed ID: 23249378
[TBL] [Abstract][Full Text] [Related]
3. Tinkering outside the kinase ATP box: allosteric (type IV) and bivalent (type V) inhibitors of protein kinases.
Cox KJ; Shomin CD; Ghosh I
Future Med Chem; 2011 Jan; 3(1):29-43. PubMed ID: 21428824
[TBL] [Abstract][Full Text] [Related]
4. Discovery and characterization of non-ATP site inhibitors of the mitogen activated protein (MAP) kinases.
Comess KM; Sun C; Abad-Zapatero C; Goedken ER; Gum RJ; Borhani DW; Argiriadi M; Groebe DR; Jia Y; Clampit JE; Haasch DL; Smith HT; Wang S; Song D; Coen ML; Cloutier TE; Tang H; Cheng X; Quinn C; Liu B; Xin Z; Liu G; Fry EH; Stoll V; Ng TI; Banach D; Marcotte D; Burns DJ; Calderwood DJ; Hajduk PJ
ACS Chem Biol; 2011 Mar; 6(3):234-44. PubMed ID: 21090814
[TBL] [Abstract][Full Text] [Related]
5. Fluorescence labels in kinases: a high-throughput kinase binding assay for the identification of DFG-out binding ligands.
Simard JR; Rauh D
Methods Mol Biol; 2012; 800():95-117. PubMed ID: 21964785
[TBL] [Abstract][Full Text] [Related]
6. Exploration and Comparison of the Geometrical and Physicochemical Properties of an αC Allosteric Pocket in the Structural Kinome.
Sturm N; Tinivella A; Rastelli G
J Chem Inf Model; 2018 May; 58(5):1094-1103. PubMed ID: 29697977
[TBL] [Abstract][Full Text] [Related]
7. Gaining Insights into Key Structural Hotspots within the Allosteric Binding Pockets of Protein Kinases.
Bhujbal SP; Jun J; Park H; Moon J; Min K; Hah JM
Int J Mol Sci; 2024 Apr; 25(9):. PubMed ID: 38731943
[TBL] [Abstract][Full Text] [Related]
8. Structure- and Similarity-Based Survey of Allosteric Kinase Inhibitors, Activators, and Closely Related Compounds.
Laufkötter O; Hu H; Miljković F; Bajorath J
J Med Chem; 2022 Jan; 65(2):922-934. PubMed ID: 33476146
[TBL] [Abstract][Full Text] [Related]
9. Drug discovery and the human kinome: recent trends.
Eglen R; Reisine T
Pharmacol Ther; 2011 May; 130(2):144-56. PubMed ID: 21256157
[TBL] [Abstract][Full Text] [Related]
10. Leveraging Structural Diversity and Allosteric Regulatory Mechanisms of Protein Kinases in the Discovery of Small Molecule Inhibitors.
Verkhivker GM
Curr Med Chem; 2017; 24(42):4838-4872. PubMed ID: 27719654
[TBL] [Abstract][Full Text] [Related]
11. A new paradigm for protein kinase inhibition: blocking phosphorylation without directly targeting ATP binding.
Bogoyevitch MA; Fairlie DP
Drug Discov Today; 2007 Aug; 12(15-16):622-33. PubMed ID: 17706543
[TBL] [Abstract][Full Text] [Related]
12. Identification of allosteric inhibitors of p21-activated kinase.
Viaud J; Peterson JR
Methods Mol Biol; 2012; 928():67-79. PubMed ID: 22956134
[TBL] [Abstract][Full Text] [Related]
13. Protein kinase inhibitors: insights into drug design from structure.
Noble ME; Endicott JA; Johnson LN
Science; 2004 Mar; 303(5665):1800-5. PubMed ID: 15031492
[TBL] [Abstract][Full Text] [Related]
14. Allosteric Regulation of Protein Kinases Downstream of PI3-Kinase Signalling.
Leroux AE; Gross LZF; Sacerdoti M; Biondi RM
Adv Exp Med Biol; 2019; 1163():279-311. PubMed ID: 31707708
[TBL] [Abstract][Full Text] [Related]
15. Occupational hazards: allosteric regulation of protein kinases through the nucleotide-binding pocket.
Cameron AJ
Biochem Soc Trans; 2011 Apr; 39(2):472-6. PubMed ID: 21428922
[TBL] [Abstract][Full Text] [Related]
16. Evolutionary variation and adaptation in a conserved protein kinase allosteric network: implications for inhibitor design.
Oruganty K; Kannan N
Biochim Biophys Acta; 2013 Jul; 1834(7):1322-9. PubMed ID: 23499783
[TBL] [Abstract][Full Text] [Related]
17. Molecular mechanism of regulation of the atypical protein kinase C by N-terminal domains and an allosteric small compound.
Zhang H; Neimanis S; Lopez-Garcia LA; Arencibia JM; Amon S; Stroba A; Zeuzem S; Proschak E; Stark H; Bauer AF; Busschots K; Jørgensen TJ; Engel M; Schulze JO; Biondi RM
Chem Biol; 2014 Jun; 21(6):754-65. PubMed ID: 24836908
[TBL] [Abstract][Full Text] [Related]
18. DFGmodel: predicting protein kinase structures in inactive states for structure-based discovery of type-II inhibitors.
Ung PM; Schlessinger A
ACS Chem Biol; 2015 Jan; 10(1):269-78. PubMed ID: 25420233
[TBL] [Abstract][Full Text] [Related]
19. Productive induced metastability in allosteric modulation of kinase function.
Montes de Oca J; Rodriguez Fris A; Appignanesi G; Fernández A
FEBS J; 2014 Jul; 281(13):3079-91. PubMed ID: 24823615
[TBL] [Abstract][Full Text] [Related]
20. Pocketome of human kinases: prioritizing the ATP binding sites of (yet) untapped protein kinases for drug discovery.
Volkamer A; Eid S; Turk S; Jaeger S; Rippmann F; Fulle S
J Chem Inf Model; 2015 Mar; 55(3):538-49. PubMed ID: 25557645
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
